Acceleron Pharma Inc (XLRN):企業財務及び戦略的SWOT分析

◆英語タイトル:Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥32,100見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,200見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥96,300見積依頼/購入/質問フォーム


Acceleron Pharma Inc (Acceleron Pharma) is a biopharmaceutical company that discovers, manufactures and commercializes protein therapeutics for treatment of cancer and other orphan diseases. The company’ pipeline product portfolio comprises drugs in the therapeutic areas of hematology, oncology and muscle. Its products cater to pathology requirements of Beta-Thalassemia, myelodysplastic syndromes, chronic kidney disease, renal cell carcinoma and hepatocellular carcinoma. Acceleron Pharma partners with various biopharmaceutical companies and research institutes to advance the development of its lead products. Its partners include Celgene Corporation, Shire plc, and Alkermes plc. Acceleron Pharma is headquartered in Cambridge, Massachusetts, the US.

Acceleron Pharma Inc Key Recent Developments

Jan 06, 2017: Acceleron Outlines Corporate Goals and Priorities for 2017
Nov 03, 2016: Acceleron Pharma Reports Third Quarter 2016 Financial and Operational Results
Sep 27, 2016: Acceleron Announces Retirement of John Knopf as President and CEO; Habib Dable Named as Successor
Aug 04, 2016: Acceleron Pharma Reports Second Quarter 2016 Financial and Operational Results
Jul 25, 2016: Acceleron Pharma Appoints Thomas McCourt to its Board of Directors

This comprehensive SWOT profile of Acceleron Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Acceleron Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Acceleron Pharma Inc – Key Information
Acceleron Pharma Inc – Overview
Acceleron Pharma Inc – Key Employees
Acceleron Pharma Inc – Key Employee Biographies
Acceleron Pharma Inc – Key Operational Heads
Acceleron Pharma Inc – Major Products and Services
Acceleron Pharma Inc – History
Acceleron Pharma Inc – Company Statement
Acceleron Pharma Inc – Locations And Subsidiaries
Acceleron Pharma Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Acceleron Pharma Inc – Business Description
Acceleron Pharma Inc – Corporate Strategy
Acceleron Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Acceleron Pharma Inc – Strengths
Acceleron Pharma Inc – Weaknesses
Acceleron Pharma Inc – Opportunities
Acceleron Pharma Inc – Threats
Acceleron Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Acceleron Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Acceleron Pharma Inc, Key Information
Acceleron Pharma Inc, Key Ratios
Acceleron Pharma Inc, Share Data
Acceleron Pharma Inc, Major Products and Services
Acceleron Pharma Inc, History
Acceleron Pharma Inc, Key Employees
Acceleron Pharma Inc, Key Employee Biographies
Acceleron Pharma Inc, Key Operational Heads
Acceleron Pharma Inc, Other Locations
Acceleron Pharma Inc, Subsidiaries
Acceleron Pharma Inc, Key Manufacturing facilities
Acceleron Pharma Inc, Key Competitors
Acceleron Pharma Inc, SWOT Analysis
Acceleron Pharma Inc, Ratios based on current share price
Acceleron Pharma Inc, Annual Ratios
Acceleron Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Acceleron Pharma Inc, Performance Chart
Acceleron Pharma Inc, Ratio Charts


★リサーチレポート[ Acceleron Pharma Inc (XLRN):企業財務及び戦略的SWOT分析(Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。